Virtu Financial LLC Beam Therapeutics Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$23.46 - $45.07 $621,361 - $1.19 Million	26,486 New	26,486 $875,000
Q1 2023 May 01, 2023	BUY	$30.15 - $48.79 $235,290 - $380,757	7,804 New	7,804 $239,000
Q3 2022 Nov 07, 2022	BUY	$39.79 - $70.31 $408,523 - $721,872	10,267 New	10,267 $489,000
Q2 2022 Aug 09, 2022	SELL	$29.86 - $62.36 $236,162 - $493,205	-7,909 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$53.73 - $82.16 $424,950 - $649,803	7,909 New	7,909 $453,000
Q4 2021 Feb 17, 2022	SELL	$68.02 - $99.06 $246,504 - $358,993	-3,624 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $305,756 - $484,166	3,624 New	3,624 $315,000
Q2 2021 Sep 17, 2021	SELL	$64.12 - $128.71 $1.43 Million - $2.86 Million	-22,256 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$71.28 - $120.75 $1.59 Million - $2.69 Million	22,256 New	22,256 $1.78 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.